Do ABOT and FMED hold the same stocks?

By their latest filings, 2% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, ABOT or FMED?

ABOT has 64% of its weight in S&P 500 names and FMED has 22%, so FMED differs more from the index.

Which is cheaper, ABOT or FMED?

ABOT charges 0.39% a year and FMED charges 0.50%, so ABOT is cheaper. Fees come from each fund's prospectus.

Data as of Nov 4, 2026.

Thematic ETFs

ABOT vs FMED: Holdings Overlap & Returns

Share on X Download as PDF

Over the year to Nov 4, 2026, ABOT returned +13.5% to FMED's +27.4%; 2% of their weight is in the same names.

askIQ about this page

askIQ about ABOT and FMED

Net assets: $4.0m on Jul 31, 2026 for Abacus FCF Innovation Leaders ETF, and $52m on Sep 30, 2026 for Fidelity Disruptive Medicine ETF.

ABOT on its own →FMED on its own →

At a glance

64.4%

ABOT in the S&P 500

21.8%

FMED in the S&P 500

+13.5%

ABOT total return, 1 year

+27.4%

FMED total return, 1 year

ABOT · 1 year to Nov 4, 2026 36% of its weight is outside the S&P 500

64% of ABOT's weight is in S&P 500 companies and 36% is outside the index. Holdings as of Jul 31, 2026.

FMED · 1 year to Nov 4, 2026 78% of its weight is outside the S&P 500

22% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.

Pair scorecard

ABOT costs 0.11 points a year less; their one-year returns differ by 13.9 points.

ABOT vs FMED: Holdings Overlap & Returns
Measure	ABOT	FMED
Return
Measure	ABOT	FMED
Total return, 1 year	+13.5%	+27.4%
Benchmark
Measure	ABOT	FMED
What it tracks	Broad innovation and megatrends	Broad innovation and megatrends
Cost and size
Measure	ABOT	FMED
Expense ratio	0.39%	0.50%
Net assets, ABOT as of Jul 31, 2026 and FMED as of Sep 30, 2026	$4.0m	$52m
Holdings
Measure	ABOT	FMED
Holdings in common	2%
Top ten holdings, share of the fund	32%	33%

Method

What they share

By the books each fund has filed, ABOT and FMED hold 2% of their money in the same securities at the same weight. Holdings dated Jul 31, 2026 and Aug 31, 2026.

50%

0 half 100%

half

2% in common

Positions both hold · largest shared weight first ABOT FMED

Alnylam Pharmaceuticals Inc 1.28% 2.33%

Dexcom Inc 1.96% 0.71%

Only in one fund ↓

Only in ABOT

Apple Inc 4.94%

NVIDIA Corp 4.75%

Broadcom Inc 3.90%

AbbVie Inc 3.25%

Airbnb Inc 2.73%

Snowflake Inc 2.68%

Bristol-Myers Squibb Co 2.61%

Adobe Inc 2.54%

Only in FMED

10X GENOMICS INC 5.19%

THERMO FISHER SCIENTIFIC INC 3.83%

DANAHER CORP 3.73%

NATERA INC 3.30%

ARGENX SE 3.20%

LIFESTANCE HEALTH GROUP INC 3.00%

REVOLUTION MEDICINES INC 2.87%

ILLUMINA INC 2.82%

Check overlap with more funds →

Window by window

Window by window: ABOT vs FMED: Holdings Overlap & Returns
	Total return
Window	ABOT	FMED
3 months	+7.7%	+14.9%
6 months	+24.2%	+31.2%
1 year	+13.5%	+27.4%
3 years	+86.1%	+57.8%
Since launchNot the same days: ABOT Dec 2020 · FMED Jun 2023	+94.5%	+31.7%

Open this comparison in the app →

Side by side

ABOT Abacus FCF Innovation Leaders ETF · Holds 50 stocks in broad innovation and megatrends, 64% of its weight in S&P 500 companies FMED Fidelity Disruptive Medicine ETF · Holds 72 stocks in broad innovation and megatrends, 22% of its weight in S&P 500 companies

Issuer Abacus FCF Fidelity

Theme Broad innovation and megatrends Broad innovation and megatrends

In the S&P 500 64.4% 21.8%

Active share vs the S&P 500 83.7% 97.5%

In the Nasdaq-100 42.3% 5.1%

Holdings 50 72

Top ten, share of the fund 32.5% 33.2%

Expense ratio 0.39% 0.50%

Fee for the differing part 0.47% 0.51%

Total return, 1 year +13.5% +27.4%

vs its benchmark not measured not measured

Below its high −3.4% −0.9%

Net assets, ABOT as of Jul 31, 2026 and FMED as of Sep 30, 2026 $4.0m $52m

As of Nov 4, 2026. Source: ETFIQ.

2% of the two portfolios are the same securities at the same weight.

Alert

About each fund

ABOT

By weight, 64% of ABOT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 84%. The top ten holdings are 32% of the fund across 50 positions, as filed for Jul 31, 2026. Over the year to Nov 4, 2026 the fund returned +13.5% with distributions reinvested.

FMED

By weight, 22% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 33% of the fund across 72 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +27.4% with distributions reinvested.

Questions people ask

Do ABOT and FMED hold the same stocks?: By their latest filings, 2% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, ABOT or FMED?: ABOT has 64% of its weight in S&P 500 names and FMED has 22%, so FMED differs more from the index.
Which is cheaper, ABOT or FMED?: ABOT charges 0.39% a year and FMED charges 0.50%, so ABOT is cheaper. Fees come from each fund's prospectus.

Other comparisons

ABOT vs THMZ ABOT vs TEKY ABOT vs FDFF ABOT vs CARZ FMED vs XDAT FMED vs BUYZ FMED vs GXDW FMED vs BULD

Where to next

All thematic ETFs ranked by the S&P 500 Difference Score →How the scores are computed →ABOT on its own →FMED on its own →ABOT dividend history →ABOT holdings →FMED dividend history →FMED holdings →Method →Standards and sources →

Sources and dates

ABOT filings on SEC EDGAR ↗

ABOT prospectus with the expense ratio (SEC) ↗

Abacus FCF website ↗

FMED filings on SEC EDGAR ↗

FMED prospectus with the expense ratio (SEC) ↗

Fidelity website ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Every number is an ETFIQ calculation with distributions reinvested.

Cite this pageCitation, APA and Markdown

ETFIQ, ABOT against FMED, data as of Nov 4, 2026. https://etfiq.com/compare/themes/abot-vs-fmed

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.